HomeBUSINESS
BUSINESS

Taiyo Pharma Eyeing 10 Trillion Yen Japanese Market, Looking to Use In-House Technologies to Develop New Products: COO
(Jan.10.2018)

Taiyo Pharma COO Masao Arima
The Taiyo Group, which is mainly involved in the manufacture and sale of chemicals for use in the electronics industries, entered the pharmaceutical industry by establishing Taiyo Pharma in August 2017. The company will initially market long-listed products (LLPs) acquired from Chugai Pharmaceutical, but its business could expand to include in-house products in the future. Under what kind of business model will Taiyo Pharma establish its presence in the pharmaceutical industry? We spoke with its COO, Masao Arima, to find out ...
(LOG IN FOR FULL STORY)

News Calendar